Sanne C F A Huijberts

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Histone Deacetylase

Prognostic Factors

Ejection Fraction

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Alaa Embaby, Sanne C F A Huijberts, Liqin Wang, Rodrigo Leite de Oliveira, Hilde Rosing, Bastiaan Nuijen, Joyce Sanders, Ingrid Hofland, Charlaine van Steenis, Roelof J C Kluin, Cor Lieftink, Christopher G Smith, Christian U Blank, Johannes V van Thienen, John B A G Haanen, Neeltje Steeghs, Frans L Opdam, Jos H Beijnen, Alwin D R Huitema, René Bernards, Jan H M Schellens, Sofie Wilgenhof
A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Alaa Embaby, Sanne C F A Huijberts, Liqin Wang, Rodrigo Leite de Oliveira, Hilde Rosing, Bastiaan Nuijen, Joyce Sanders, Ingrid Hofland, Charlaine van Steenis, Roelof J C Kluin, Cor Lieftink, Christopher G Smith, Christian U Blank, Johannes V van Thienen, John B A G Haanen, Neeltje Steeghs, Frans L Opdam, Jos H Beijnen, Alwin D R Huitema, René Bernards, Jan H M Schellens, Sofie Wilgenhof
A proof-of-concept study of sequential treatment with the HDAC inhibitor vorinostat following BRAF and MEK inhibitors in BRAFV600mutated melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sanne C F A Huijberts, Mirjam C Boelens, Rene Bernards, Frans L Opdam
Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +/- binimetinib or alpelisib. British journal of cancer 124 (1) (2020)